Canopy Rivers portfolio company, TerrAscend has received approval from Health Canada for a significant expansion at its Mississauga, Ontario facility. "TerrAscend expects that this milestone will help the company meet the increased consumer demand for premium cannabis products and brands coming with the next wave of Canadian cannabis legalization," the team with the company explains. "As the first and only cannabis company with sales in Canada, the U.S., and Europe, TerrAscend has also earmarked the additional capacity to further serve the global markets where it operates."
"With this approval, TerrAscend's licensed space nearly triples to 51,800 sq. ft. and includes additional cultivation capacity, a commercial kitchen, formulation rooms and increased primary and secondary packaging capacity. First licensed for cultivation in July 2017, TerrAscend's 67,300 sq. ft. EU GMP certified indoor cannabis facility is focused on serving the Canadian medical and adult-use markets, conducting research & development for plant sciences and formulations, and serving as a platform for export of cannabis products to Europe and other international jurisdictions."
For more information: